Log In
Print
BCIQ
Print
Print this Print this
 

Entresto, sacubitril/valsartan (LCZ696)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionCrystalline complex of valsartan, an antagonist of angiotensin II type 1 (AT1) receptor (ATGR1), and sacubitril, an inhibitor of neutral endopeptidase (neprilysin; MME; NEP; CD10), in an equimolar ratio
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1) ; Neutral endopeptidase (neprilysin) (MME) (NEP) (CD10)
Mechanism of ActionNeutral endopeptidase inhibitor; Angiotensin II type 1 (AT1) receptor (ATGR1) antagonist
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today